Skip to main content
Clinical Trials/CTRI/2025/02/081267
CTRI/2025/02/081267CompletedNot Applicable

An Observational study to assess role of Transnasal Humidified Rapid Insufflation Ventilatory Exchange with Target Controlled Infusion as sole airway management during Endoscopic Retrograde Cholangiopancreatography

Dr Ilancheran J1 site in 1 country56 target enrollmentStarted: March 21, 2025Last updated:
Conditions
Drugs

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
56
Locations
1
Primary Endpoint
To assess the number of episodes of desaturation and duration of desaturation

Study Overview

Brief Summary

Patients fulfilling the inclusion criteria are selected.The appropriate details are filled in the proforma and consent obtained. The primary objective is to assess the number of episodes of desaturation and duration of desaturation.The secondary outcomes would be to assess the total propofol used, end tidal co2, arterial blood gas at the beginning & end of procedure, need for rescue ventilation, time taken to respond to oral commands, incidence of sore throat or dryness, hemodynamics at thrive removal, patient satisfaction and results are withdrawn.

Study Design

Study Type
Interventional
Allocation
Na
Masking
None

Eligibility Criteria

Ages
18.00 Year(s) to 75.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • •Body mass index less than 40kg/m2 American Society of Anaesthesiologists(ASA 1-3).

Exclusion Criteria

  • •Patients younger than 18 years of age Anticipated difficult airway.
  • •P a r t u r i e n t Risk of aspiration Hemodynamic instability Heart disease Emergency surgeries Allergy to propofol Patient refusal Inability to give consent to the study.

Outcomes

Primary Outcomes

To assess the number of episodes of desaturation and duration of desaturation

Time Frame: Intraoperative ( Beginning to end of procedure)

Secondary Outcomes

  • Total Propofol used(End Tidal Co2)

Investigators

Sponsor
Dr Ilancheran J
Sponsor Class
Other [self]
Responsible Party
Principal Investigator
Principal Investigator

Ilancheran J

Sri Ramachandra Institute of Higher Education and Research

Study Sites (1)

Loading locations...

Similar Trials